Should You Invest in Atricure Inc (ATRC) Now?

The 36-month beta value for ATRC is at 1.40. Analysts have varying views on the stock, with 5 analysts rating it as a “buy”, 4 rating it as “overweight”, 1 as “hold”, and 0 as “sell”.

The public float for ATRC is 47.89M, and currently, shorts hold a 5.24% of that float. The average trading volume for ATRC on February 12, 2026 was 504.55K shares.

ATRC stock’s latest price update

Atricure Inc (NASDAQ: ATRC)’s stock price has decreased by -13.11% compared to its previous closing price of $37.86. However, the company has seen a -10.61% decrease in its stock price over the last five trading sessions. zacks.com reported 2026-02-10 that AtriCure (ATRC) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ATRC’s Market Performance

ATRC’s stock has fallen by -10.61% in the past week, with a monthly drop of -12.61% and a quarterly rise of 2.83%. The volatility ratio for the week is 5.81% while the volatility levels for the last 30 days are 4.93% for Atricure Inc The simple moving average for the last 20 days is -12.97% for ATRC stock, with a simple moving average of -6.81% for the last 200 days.

Analysts’ Opinion of ATRC

Many brokerage firms have already submitted their reports for ATRC stocks, with JP Morgan repeating the rating for ATRC by listing it as a “Neutral”. The predicted price for ATRC in the upcoming period, according to JP Morgan is $36 based on the research report published on February 11, 2026 of the current year 2026.

JP Morgan, on the other hand, stated in their research note that they expect to see ATRC reach a price target of $40. The rating they have provided for ATRC stocks is “Overweight” according to the report published on December 17th, 2024.

JMP Securities gave a rating of “Mkt Outperform” to ATRC, setting the target price at $60 in the report published on October 23rd of the previous year.

ATRC Trading at -15.82% from the 50-Day Moving Average

After a stumble in the market that brought ATRC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -23.82% of loss for the given period.

Volatility was left at 4.93%, however, over the last 30 days, the volatility rate increased by 5.81%.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ATRC starting from WEHRWEIN SVEN, who sold 4,967 shares at the price of $38.00 back on Nov 25 ’25. After this action, WEHRWEIN SVEN now owns 34,374 shares of Atricure Inc, valued at $188,746 using the latest closing price.

WEHRWEIN SVEN, the Director of Atricure Inc, sale 5,033 shares at $37.32 during a trade that took place back on Nov 24 ’25, which means that WEHRWEIN SVEN is holding 34,374 shares at $187,832 based on the most recent closing price.

Stock Fundamentals for ATRC

Current profitability levels for the company are sitting at:

  • -0.05% for the present operating margin
  • 0.75% for the gross margin

The net margin for Atricure Inc stands at -0.06%. The total capital return value is set at -0.05%. Equity return is now at value -6.11%, with -4.60% for asset returns.

Based on Atricure Inc (ATRC), the company’s capital structure generated 0.14 points at debt to capital in total, while cash flow to debt ratio is standing at 0.56. The debt to equity ratio resting at 0.16. The interest coverage ratio of the stock is -3.64.

Currently, EBITDA for the company is -$18.53 million with net debt to EBITDA at 11.37. When we switch over and look at the enterprise to sales, we see a ratio of 3.02. The receivables turnover for the company is 8.23for trailing twelve months and the total asset turnover is 0.82. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.87.

Conclusion

In conclusion, Atricure Inc (ATRC) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.